Podcast: Unlocking the Potential of Transomics in Biotech

In this enlightening episode, the Artificial Intelligence podcast sat down with Samantha Dale Strasser, the co-founder and CSO of Pepper Bio, a pioneering company in the world of transomics drug discovery. Discover the vital role of phosphoproteomic data, the challenges and innovations in integrating multiple -omics layers, and how AI is set to revolutionize clinical trials and drug discovery. Join us on this journey as we explore the foundation of…

Comments Off on Podcast: Unlocking the Potential of Transomics in Biotech

Podcast: Using Transomics In Drug Discovery

Samantha Dale Strasser is the Chief Science Officer and co-founder of Pepper Bio. Pepper Bio is the world's first transomics analysis company. Transomics involves analyzing a wealth of biological information from genomics all the way up to more functional data of phosphoproteomics. Pepper Bio is able to see more relevant disease insights about how to best treat disease and how to characterize potential drugs that can be used as therapeutics.…

Comments Off on Podcast: Using Transomics In Drug Discovery

Podcast: Building Careers in Biotech

"As a PhD, you're very focused on the question and the process of how you get things done. Our focus [as a Biotech company] is on what impact we want to have, where we're going and the key questions that our partners are trying to answer." Samantha Dale Strasser is the Chief Scientific Officer of Pepper Bio, the world's first transomic analysis company. Samantha joined us in a fascinating discussion…

Comments Off on Podcast: Building Careers in Biotech

Podcast: In Conversation with Simon Fricker

DDW’s Megan Thomas is in conversation with Dr Simon Fricker, who just last year was made Chief Development Officer of PepperBio to support the company’s next phase of growth and guide the strategic expansion of Pepper’s oncology pipeline. Over the course of his career, including eight years as a distinguished scientific fellow at Genzyme/Sanofi, Dr Fricker worked on three approved drugs: Paraplatin, Fosrenol, and Mozobil. Dr. Fricker was a founder of…

Comments Off on Podcast: In Conversation with Simon Fricker

Podcast: Making Science Open to All

There are very few sciences Dr. Strasser hasn't studied, from mathematics to engineering and biology. Now she is the CSO of Pepper Bio, a drug discovery company that uses AI and other clever algorithms to treat patients more effectively. In short, Dr. Strasser is using her gifts to help others and it was inspiring and right-sizing to speak with such a humble trailblazer. Listen here to learn how Pepper is…

Comments Off on Podcast: Making Science Open to All

Podcast: Transforming Drug Discovery Through the Emerging Discipline of Transomics

Samantha Dale Strasser has always wanted to make a positive impact on humanity, and this desire was intensified while in grad school when her father was diagnosed with frontal temporal dementia — an illness with no effective treatments. Never afraid to ask the hard questions, this personal experience propelled her academic and biotech career toward driving science to address unmet medical needs. Using her skills in biomedical engineering, computer science,…

Comments Off on Podcast: Transforming Drug Discovery Through the Emerging Discipline of Transomics